Industrifonden is Sweden's venture capital fund, backing transformative ventures with breakthrough technologies and science that have a meaningful impact on society. The firm manages SEK 5 billion in assets and writes first checks of SEK 10–50 million, investing across three core areas: deep tech (advanced materials, industry 4.0, energy, advanced computing, AI, synthetic biology), life science (biotech, medtech, healthtech addressing unmet medical needs), and transformative tech (B2B-focused innovations creating tomorrow's industries). Based in Stockholm with reach across the Nordics, Industrifonden partners with passionate founders to scale unique, scalable innovations globally. The portfolio includes companies like TrusTrace (supply chain traceability), Pixelgen Technologies (protein analysis), Telness Tech (cloud telecom), Treebula (forestry tech), AnaCardio (heart failure therapeutics), Asgard Therapeutics (cancer immunotherapy), ZeroPoint (chip performance optimization), and EnginZyme (enzyme-based manufacturing). The firm provides long-term, hands-on support to transform research into commercial success.

Profile auto-generated from public sources — details unverified.